A 50-year-old woman, para 10, had had a postpartum hemorrhage at 40 years, followed by failure of lactation, amenorrhcea and loss of body hair. For two years she had complained of weakness, lethargy and marked weight loss and, more recently, of mild polydipsia and polyuria.
She was clinically thyrotoxic, having a goitre with bruit, a sinus tachycardia and bilateral lid retraction. Four-hour thyroid gland 1311 uptake was 98%O (normal <4000), PBI 15-2 ILg/l 00 ml (normal 3-5-8-5), 125J T3 serum uptake 2-0 (normal 0-90-1 16). The serum was positive for long acting thyroid stimulator (LATS), thyroid microsomal antibody and thyroglobulin antibody. Glycosuria marked (2g/100ml). No ketonuria. Blood sugar 372 mg/100 ml. Plasma 1 -OHCS 86 ,ug/100 ml at 08 30 hours (normal <26); 32,±g/100 ml at 24 00 hours (normal < 10).
She was treated with carbimazole, propranolol and digoxin. Soluble insulin 20 units subcutaneously was followed by profound hypoglycemia, which responded quickly to intravenous glucose. The patient died three days after admission.
The thyroid histology was that of a thyrotoxic gland with some focal thyroiditis. The adrenals showed predominantly compact cells in zona fasciculata (normal reaction to stress). There was no obvious abnormality in the pancreas. In the pituitary was an infarct, the remaining tissue consisting mainly of chromophobes; some corticotrophs were present but no somatotrophs, gonadotrophs or thyrotrophs.
Thyrotoxicosis in a patient with Sheehan's syndrome has been reported on only one previous occasion, by Fajans (1958) . This association is of particular interest as it provides additional clinical evidence that excessive secretion of thyroid stimulating hormone (TSH) by the pituitary gland is not the cause of thyrotoxicosis. The presence of LATS in high titre in a case where the pituitary was largely infarcted and consisted mainly of chromophobe cells and some corticotrophs, is in keeping with a non-pituitary origin for LATS. A baby girl born at full term, of normal weight for dates, and of normal pregnancy and delivery, was abnormally lethargic on the fourth day of life. Hypoglycemia was found and was treated with intravenous glucose and intramuscular hydrocortisone and glucagon, with apparent improvement. At 3 weeks of age she was again found to be hypoglycxmic and this time the hypoglycxemia could not be satisfactorily controlled. The only abnormal biochemical findings were markedly elevated plasma and urinary insulin levels and an increased glucose disappearance rate following glucose loading. She had a normal catecholamine response to hypoglyccmia.
She was treated with diazoxide (13 mg/kg/day), hydrochlorthiazide and four-hourly feeds of milk and solids, with reduction in insulin production and improvement in the blood glucose levels. However, she developed several minor upper respiratory tract infections as well as roseola infantum, on which occasions it was not possible for her mother to continue feeding her and she did not receive her medication, so that she developed hypoglycemic attacks which were occasionally associated with fits.
Laparotomy showed no macroscopic islet cell tumour of the pancreas and a subtotal pancreatectomy was performed; the histology of the pancreas was normal. Post-operatively the blood glucose levelscontinued to remain low, despite normal insulin levels, but her clinical condition was improved. The diagnosis remains obscure. It may be difficult to distinguish between 'idiopathic' hirsutism and treatable causes of virilization; the following case of virilizing ovarian tumour illustrates the value of urine testosterone estimations in such cases. 
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History: Mrs J P presented at the age of 32 with hirsutism, secondary amenorrhoea and twelve years of infertility. Her childhood had been normal apart from a tendency to obesity. Periods started at the age of 1 1, but at 17 became irregular, with excessive hair growth. Two years later she married, her periods stopped and sh'_ started to shave; at that time she weighed 12 stone (76 kg). Hair and obesity increased over the subsequent ten years, her maximum weight reaching 16 stone (101 kg). In 1967, after an unsuccessful therapeutic trial of cortisone 25-50 mg daily for six months, she was referred to the Middlesex Hospital for further investigation. There was no relevant family history.
On examination: Obese energetic woman with facial and pectoral plethora and prominent cutaneous strie. Good Progress: A laparotomy was done by Mr R L Lloyd-Jones on 1.2.68. A left ovarian tumour was found and a salpingo-oophorectomy performed. The right ovary, which appeared normal, was biopsied. Menstruation returned twenty-eight days later and the urine testosterone on 9.2.68 was 6-4 Cug/24 h. When seen on 25.3.68 she had lost a little weight but there had been no change in the hair growth. Pathology: The tumour was a well-circumscribed lobulated rubbery yellow mass, with focal areas of hemorrhage; it measured 5 cm in diameter. It had expanded rather than invaded the adjacent ovarian tissue and was surrounded by a wellmarked 'capsule' of compressed stroma, suggesting an origin in the medulla rather than the hilum of the ovary.
Microscopically (see Fig 1) the tumour was composed of two types of lipid-laden cell. One, containing Reinke crystalloids, resembled both ovarian hilus and testicular Leydig cells; the other type resembled cells of the adrenal cortex. Neither mitotic activity and pleomorphism nor evidence of malignancy were seen. The biopsy of the other ovary was histologically normal.
Comment
In a woman in whom pelvic examination revealed no abnormality, the preoperative diagnosis was based almost entirely on the estimation of urine testosterone, which was raised to 5-10 times normal, and could not be suppressed by dexamethasone; with a normal urine oxosteroid level, this strongly suggested ovarian pathology.
In the investigation of hirsutism, i-outinely available biochemical tests are often unhelpful, whereas urine testosterone estimations may frequently be of value. Slightly raised levels of testosterone may occur in the absence of demonstrable adrenal or ovarian lesions; in these 'idiopathic' cases eiiher dexamethasone or ethinyl cestradiol may be suppressant, and exhibition of small doses of the relevant hormone then provides a rational form of therapy. There is little information about urine testosterone levels in patients with virilizing ovarian tumours; however, Rosner et al. (1965) have reported greatly elevated values in two such patients, and also in another with congenital adrenal hyperplasia. The highest level was in a woman with a virilizing tumour similar to that reported here; the level was unaffected by ACTH or dexamethasone but doubled after human chorionic gonadotrophin (Rosner et al. 1964) .
Virilizing lipid-cell tumours of the ovary are very rare, the world literature containing only about 50 cases (Dunnihoo et al. 1966) . A striking clinical feature is the obesity, strix and plethora, suggesting Cushing's syndrome. These tumours have been variously named according to their morphology or systemic effects. The terms 'hilus cell tumour', 'adrenal rest tumour', 'masculinovoblastoma' and 'luteoma' have been used, but Taylor & Norris (1967) have pointed out the inadequacy of some of these names; the tumours arise in the medulla rather than the hilum of the ovary, and intra-ovarian adrenal rests have not been convincingly demonstrated. The one feature which they all have in common is the presence of abundant intracellular lipid; thus it seems more acceptable to call them 'lipid-cell tumours' qualified by 'virilizing' when applicable. Although the majority of lipid-cell tumours are associated with endometrial atrophy, hyperplasia may coexist paradoxically with virilization and rarely a decidual reaction is found with a high urine pregnanediol. These tumours probably arise from the versatile ovarian stromal cells, which can change to resemble both hilus and adrenocortical cells and have androgen and cestrogen producing potential.
